The future of pharmacy practice research - Perspectives of academics and practitioners from Australia, NZ, United Kingdom, Canada and USA by Babar, Zaheer-Ud-Din et al.
TITLE: The future of pharmacy practice research – Perspectives of academics and 
practitioners from Australia, NZ, United Kingdom, Canada and USA 
ABSTRACT 
Introduction: Healthcare is under significant pressure with the explosion of long term 
conditions, shift in worldwide demographics and is evolving through advances in 
technology. Aligned with this is the changing role of pharmacy from the traditional 
dispenser of medicines to having (in addition) a more advanced clinical role. This study 
aimed to understand what the pharmacy practice research agenda might look like from 
the viewpoint of pharmacy academics and practitioners across five high-income 
countries.  
Method: Qualitative methods were used and thirty one-hour interviews were undertaken 
with practitioners and academics from five economically advanced countries. These 
nations have comparable socio-economic status but differing health systems and include; 
Australia, Canada, New Zealand, United Kingdom and United States of America. Six 
key informants were chosen from each country, three academics and three community 
pharmacists. A general inductive analysis was undertaken to analyse the most common 
and recurring themes. 
Results: These themes of research were based around current community pharmacy 
practice issues and the enablers to changing the profession. Specific areas pharmacy 
practice could be more involved with included; care of the elderly population, mental 
health, and specialty care for the population with multiple co-morbidities. Some 
community pharmacists also felt research into the impact of professional standards and 
policy change would be beneficial. The findings of this research suggest that current 
pharmacy practice research methods are sufficient, but need to be used more effectively.  
Conclusion:  Participants identified a wide range of issues within community pharmacy 
practice. Academics largely focused on how research can be utilised in the community 
and how to implement findings to ensure sustainability of pharmacy practice research.  
Issues that community pharmacists would like to research are related to the current 
practice model, such as allocating time to provide all the patient focused services on top 
of managing a business.  
  
 
INTRODUCTION 
Worldwide, the population is growing, ageing and changing. A World Health 
Organisation report (2015) highlighted these changes in demographics; the proportion of 
the world’s population over the age of 60 is growing at a higher rate than any other age 
group and is predicted to more than double by the year 2050, from 901 million in 2015 to 
2.1 billion. This shift in the demographic can in part be attributed to success in 
healthcare, including advance in technology, nutrition and lifestyle, which in turn has 
enabled people to live longer (1, 2). This has resulted in more people with long term 
health conditions, some of whom are better informed, due to their ability to research 
health information via the internet. In parallel, medicines use and healthcare delivery are 
also evolving; this is also reflective to some degree upon the long term conditions that are 
increasing, and the rapid changes in the use of technology (2).  In addition, as the world’s 
population is more mobile than ever before and thus more multicultural; there is concern 
over health disparities within the subsequent minority populations (2-5).  
Together, these changes have an effect on healthcare demand and the potential to impact 
the way medicines are used, the policies regarding medication use, the delivery of 
healthcare and the provision of services in the pharmacy (10, 11). The increased demand 
on primary health care services (6) have led to a strain on the primary health care 
workforce (7-10). In order to overcome such challenges, primary health care systems 
have evolved to encompass new services and, in many countries, extended roles for 
community pharmacists (11-13).  
Pharmacists are medication experts and are a vital member of the healthcare team; they 
have an important role to play in the delivery of primary care in the community (2, 14). 
Community pharmacists have been described as the most easily accessible healthcare 
professional and a community pharmacy is a common point of contact for patients to 
access medicines and healthcare advice (2, 15). Effective medicines management and the 
expanding roles of pharmacists must be coupled with a well-organised technology 
infrastructure, professional training and  ethical, legal and regulatory frameworks (16).  
In an evidence-based health service, it is vital to show evidence of benefit to support 
these changing roles and perceptions of the pharmacist (17, 18). Due to the increasingly 
integrated nature of pharmacy within the healthcare profession, practicing pharmacists 
need to actively participate in research in order to reflect on the relevancy of the services 
they deliver, to help discover new areas that may require research, and to firmly establish 
the necessity of the profession (2). For this reason, it is vital to evaluate what community 
pharmacy practice may look like in the next 20-30 years and the types of questions that 
might need answering by pharmacy practice researchers.  
 
The aim of this study was to understand what a future community pharmacy practice 
research agenda might look like from the viewpoint of pharmacy academics and 
practitioners. Specifically, to compare and contrast the perceptions of academics and 
practising pharmacists, in addition to exploring new methods which may be used in the 
future by pharmacy practice researchers. 
 
METHODS 
Study design and participant selection 
This study adopted a qualitative approach using semi-structured exploratory interviews 
between June and October 2015 via telephone, Skype or face-to-face meetings. Ethical 
approval for the study was gained from the University of Auckland Human Participants’ 
Ethics Committee (Reference: 014653).  Purposive sampling was used to select community 
pharmacists and academic pharmacy researchers from Australia, Canada, New Zealand, the 
UK and USA.  Participants within these countries were selected due to the country’s similar 
socioeconomic standing. Selection criteria for academic participants included prior sector 
knowledge of researchers working in academia and identifying individuals who had 
previously published articles relating to community pharmacy practice. For community 
pharmacist participants, selection was from those actively posting about their work on social 
media platforms such as LinkedIn and Twitter. Additional participants were also identified 
using a snowball sampling strategy following recommendations made by interviewees. 
 
When identified, participants were contacted via email to introduce the study and were 
invited to participate. If the participants replied with interest, a participant study information 
sheet explaining the purpose of the research and their role within it was sent, along with a 
research consent form and the semi-structured interview guide. For those agreeing to 
participate in the study and who returned a signed consent form, an interview was arranged at 
a convenient time. 
Development of Interview Schedule 
The purpose of the interview was to identify research themes that pharmacy practice 
academics and community practitioners thought should be explored in order to inform a 
future community pharmacy research agenda. A semi-structured interview guide was 
developed for this purpose, following a review of the literature which consisted of six key 
areas to be explored (see Table 1). The guide was piloted using two individuals, one an 
academic, the other a community pharmacist, and refined prior to conducting the main 
interviews. The schedule was designed to establish an overview of current community 
pharmacy practice and community pharmacy practice research from each participant before 
enabling exploration of any emerging themes as the interviews progressed. 
Six sections of the semi-structured interview guide 
Sections Including: Literature-derived themes to inform interview  
1 Community 
pharmacy 
practice in their 
respective 
countries 
a) Situation 
b)     Issues 
  The perception of the role of the pharmacist in the 
provision of care,  
 Transition of the profession 
 Lack of resources 
 Pharmacists’ collaboration with other healthcare 
professionals 
2 Community 
pharmacy 
practice research 
a)     Issues with research 
b)     Explanation on why they see these as 
issues 
 Lack of awareness, time and resources  
 Lack of a research agenda 
 Lack of funding 
3 The enablers of 
pharmacy 
practice research 
Impacts of: 
a)     Consumers 
b)     Technology 
c)     Demographics 
d)     Education and professional standards 
 Impact on funding 
 Use of mobile technologies and databases on service 
delivery 
 Ageing population Ethnicity and migration 
Language barriers 
 Integration between researchers and pharmacists 
Link to service provided to patients 
4 The impact of 
pharmacy 
practice research 
a)     Research required to change policy 
b)     Research used in past that worked and 
was useful 
 Using evidence-based research and implementing it 
into practice 
5 Future of 
pharmacy 
practice and 
associated 
research 
  
a)     Key to sustained pharmacy practice 
b)     Views of the future of pharmacy 
practice research 
c)     Factors that may influence pharmacy 
practice research on a global level 
 Collaboration, use of electronic health records 
continued learning for pharmacists 
 Collaborative research, proving value of services 
 Value of pharmacist in the primary care team, 
pharmacist communication 
 New, innovative models of care, Global workforce 
6 Methodologies  
used in practice 
research 
a)     Sufficiency of current methodologies 
b)     Any new methods and models that 
may emerge 
c)     How they may impact practice 
research 
 Sufficiency dependent on research question 
 Use of technology, application of existing methods 
from other disciplines 
 Stronger research 
Table 1: Overview of the six themes in the semi-structured interview guide and the resulting themes that emerged. 
Data analysis 
All interviews were audio recorded and transcribed verbatim by the interviewer. This allowed 
for familiarisation with the data and initiated an informal coding process with the emerging 
themes. The transcripts were entered into QSR NVIVO 10© for categorical coding according 
to the questions asked in the interview. Pre-determined parent nodes were set up to align with 
the six areas to be explored in the interview guide. Child nodes were created based on the 
questions asked in each category. Further sub-nodes were assigned according to similarity of 
emerging themes. Transcripts and codes were checked by the supervising academic to ensure 
the quality and accuracy of the data. 
  
RESULTS  
Study participants 
Seventy-seven participants were approached about this study; 38 academics and 39 
community pharmacists. A total of 30 individuals were interviewed for this study. This 
included 15 academics and 15 community pharmacists, three from each category in each 
country. The interviews were conducted via telephone, Skype™ or in person. All interviews 
were digitally recorded and transcribed verbatim by the research team. The completed 
transcriptions were read over, checked, and then sent to the participants for feedback.  They 
were given one week to check and revise the transcripts. All revised transcripts and 
transcripts which were not sent back by the deadline were entered into the NVivo 10 (QSR 
International Pty Ltd) software package for the qualitative data analysis phase. 
 
Main themes 
Participants were asked the questions outlined in the semi-structured interview guide (table 
1). Pre-determined themes that formed the basis of the interview questions were discussed 
and emergent sub-themes from this dialogue were categorised according to each section of 
the guide. An overview of the literature derived themes can be seen in table 1. Further 
details and evidence for these themes and sub-themes are described in tables 3-8.
Country  Gender Academic Rank 
Approximate publication category as of year of 
interview* 
Independant versus chain 
pharmacies 
New Zealand Academics 2F, 1M 2 AP/Ps, 1 SL/L 1 x Category 2; 1 x Category 3 and 1 Category 4 - 
Community pharmacists 1F, 2M 
- - 
1 independent, 1 chain and 1 both 
CPs 
Australia Academics 2F, 1M 2 AP/Ps, 1 SL/L 1 x Category 2, 1 x Category 3 and 1 x Category 4 - 
Community pharmacists 1F, 2M - - 2 independent and 1 chain CP 
Canada Academics 3M 2 AP/Ps, 1 SL/L 1 x Category 1; 1 x Category 2 and 1 x Category 4 - 
Community pharmacists 1F, 2M - - 3 independent CPs 
UK Academics 3F 3 AP/Ps 1 Category 3 and 1 x Category 4 - 
Community pharmacists 1F, 2M - - 3 independent CPs 
USA Academics 2F, 1M 3 AP/Ps 1 x Category 1, 1 x Category 2 and 1 x Category 3 - 
Community pharmacists 2F, 1M - - 1 independent and 2 chain CPs 
  Table 1: Characteristics of participants. Associate/Assistant Professor/Professors = AP/P; Senior Lecturer/ Lecturer = SL/L (or equivilant). Community Pharmacy = CP 
* Categories of publication history = Category 1 <25; Category 2 26-50; Category 3 51-150; Category 4 >150 
 Issues relating to community pharmacy practice 
There were four themes raised by participants as key issues surrounding community pharmacy practice. These were (1) the perception of the 
role of the pharmacist in the provision of care and how it could be a barrier in moving the profession forward, including the consumer’s view, 
(2) the transition of the profession -- moving from the role of the dispenser to a service-based model, (3) a lack of resources and (4) the 
collaboration of pharmacists with other healthcare professionals. These themes are explored below. 
Table 3: Themes that emerged from the discussion surrounding community pharmacy practice 
Theme Explantory note Evidence 
(1) Perceptions of the 
role of the pharmacist 
in the provision of 
care 
 
The perception of the role of the pharmacist could be a barrier in 
moving the profession forward. 
 
“There are always big public relations questions among the pharmacy associations 
because people don’t understand what we do and how we do it and what goes on behind 
the scenes.” [CP6-USA] 
“…whether they are just a retail outlet or they are a primary care provider.” [CP1-Australia] 
 
Perception and understanding of the role of the profession by 
consumers. 
 
“… pharmacists are trusted a lot of times but this does not necessarily translate into 
understanding what pharmacists can do” [A4-Canada]. 
 
(2) Transition of the 
profession- moving 
from a dispensing 
model to a service-
based model 
 
 
 
Participants agreed the need for a new pharmacy model based on the 
delivery of pharmaceutical care to patients. Many suggested that this 
could be enabled further by having a team of competent technicians in 
dispensing roles so that pharmacists could provide these services.  
 
“…dispensing on its own is not going to be sustainable and that there needs to be an 
acceptance of the need to provide services that are quality-based, that are evidence-
based…”  [A3-UK] 
 
More robust and broad research  is needed to be carried out before it 
can be implemented within existing healthcare models. 
 
“...there’s a lot of places where evidence is lacking for pharmacy.” [CP9-Australia] 
 
Many participants believed the profession will move forward to a more 
clinical role but the problem is whether pharmacists will take the 
opportunity to become more involved, even when this change is 
implemented as part of the expanded scope of practice. 
 
“Pharmacists are notorious for whining and complaining about not being able to do things and 
then when given the opportunity to do it, they don’t.” [A5-Canada] 
 
Another factor that could affect the transition of the profession is 
whether the profession has leaders to strongly advocate for change. A 
few participants identified this as a barrier. 
 
“…if you ever needed a time for clear and effective leadership is now because what I think the 
profession needs is a strong voice, a very confident voice, and you know, leadership becomes 
critical.” [A6-NZ] 
 
 Pharmacists feel that this service model is the best approach for the 
future of pharmacy practice because in the past the dispensing model 
was based around an acute care setting but as the population ages and 
patients are faced with multi-morbidity, this shift to a more supportive 
and problem-solving role through the provision of clinical services is 
needed. 
 
“...that is a big problem with regards to medicine use for the community is particularly around 
multi-morbidity and the treatment of things that go along side in an aged 
population….pharmacy needs to be in that space that’s not a dispensing space, it’s about 
solving the problems of multi-medicine use.” [A3-Australia] 
 
(3) Lack of resources Although there was agreement that the model of care should be more 
service-based, participants identified that funding for the provision of 
services may be limited. The responses varied based on the model of 
care in that particular country.  
 
“I guess the other thing is that the NHS is a bit cash-strapped at the moment so it is 
difficult to get some services commissioned, both nationally and on a local level as well.” 
[CP1-UK] 
“I think that depending on how insurance works…there won’t be too many services 
involved because it costs so much money.” [CP 2-USA] 
“…they want to know what’s it gonna, how it’s gonna impact the budget. So if it’s gonna save 
in-patient days, so we use less beds then you need to show that. It can’t be just the clinical 
outcome, but how’s it gonna save money in the long run.” [A4-Canada] 
 
Also a NZ community pharmacist identified that the lack of time 
pharmacists have available limits the services provided in pharmacies. 
 
“...we probably need to be in a position where we really should have time for it… ” [CP5-NZ] 
 
(4) Pharmacists’ 
collaboration with 
other healthcare 
professionals 
Both academics and community pharmacists were concerned about the 
implications of providing more clinical services on the work of other 
healthcare professionals. However, they did agree that collaboration 
with general practitioners was needed to streamline patient care. 
 
“I think there’s a fear of just doing it and moving forward… they don’t want to upset 
doctors and I don’t think the doctors are really going to be upset if pharmacists are active 
and doing things.” [A1-UK] 
“... when we start to change what we do, are we going to tread on anybody else’s toes?” [CP5-
NZ] 
 Participants agreed that there needs to be a seamless co-operation with 
other health professionals.  
“...[without cooperation, patients will] end up back in the hospital within the first week so they 
you know end up spending more money than what they would spend on one or two weeks 
medication supply” [CP7-Canada] 
 A participant also stated that to provide better care there is a need to 
access patient records and information to get a complete profile on the 
patient, which requires complete cooperation between different 
healthcare professionals. 
 
“I believe we should have access to patient's profile or their entire profile for last year or so… 
so that we can manage their care better” [CP7-Canada] 
 
 
2. Issues relating to community pharmacy practice research 
Three main themes emerged as key issues related to community pharmacy practice research. These were; (1) a lack of awareness, time and 
resources, ( 2 ) lack of a research agenda and (3) a lack of funding. 
Table 4: Themes that emerged from discussion surrounding issues relating to community pharmacy practice research 
Theme Explantory note Evidence 
(1) Lack of 
awareness, time 
and resources 
 
Participants identified a lack of integration between community 
pharmacy practice and practice research. Academics thought that 
there needed to be more of a research culture within community 
pharmacy but community pharmacists expressed that they didn’t 
have time for it beyond their current responsibilities. 
“I think most community pharmacies, they’re not necessarily what we call research ready.” 
[CP3-UK] 
“I think a big issue is actually getting people to participate.” [A5-Canada] 
“I think the major issue is definitely the time, lots of pharmacists do not have time and 
resources to think or initiate a research project or think about doing a research project.” 
[CP1-Australia] 
(2) Lack of a 
research agenda 
 
Participants stated a lack of a research agenda, which is needed to 
facilitate futire community pharmacy practice research. Academics 
mentioned the need for multidisciplinary collaboration. 
“I believe that there should be a call and some sort of agreement…where we can get 
top researchers and top policymakers to agree on an agenda and come  together on 
that rather than the very fragmented nature in which we see in now.” [A2-USA] 
Participants felt that in order for the profession to grow and change 
there needs to be evidence to show that pharmacists are making a 
difference, otherwise the government will not be interested in 
funding and developing services further. 
 
“... if we can’t show that it is providing some kind of benefit, then, if we are looking for 
funding for that service from the government we will be challenged about why we are 
providing that service when it is not really having any impact.” [A2-NZ] 
“...some aspects of research you see around the clinical aspects but I don’t think there’s any 
or barely any research that is pharmacy specific and around the interaction, the social 
interaction between the pharmacy, the pharmacist and the individual. So, there’s just very 
little quality research that is going out and assessing whether or not the pharmacist is doing a 
good job with that patient.” [CP3-NZ] 
 
(3) Lack of funding 
 
Participants thought that there was a lack of funding for pharmacy 
practice research.  
“… funding, because at the moment, a lot of community pharmacy practice research is 
not of a sufficient calibre in terms of scope or design to be considered as evidence in 
the NHS.” [A4-UK] 
“So, you can only do that by pretty massive investment and that’s got to come from the 
profession, it’s got to come from the funders…” [A6-NZ] 
 
3. Enablers to pharmacy practice research 
The four enablers of pharmacy practice research were consumer involvement, technology, patient demographics and education and 
professional standards were discussed with participants. Key themes identified can be seen in table 4 below. 
Table 5: Themes that emerged from discussion surrounding enablers to pharmacy practice research 
Theme Explantory note Evidence 
(1) Consumer 
involvement 
Importance of consumer opinion “…obviously patients’ involvement is vital, because we can think of all sorts of wonderful things to do but if our patients either 
don’t want it or don’t appreciate it, what’s the point?” [CP4-UK] 
“I think not all research needs to involve participants…but I think certainly some of it should. Particularly if it involves 
pharmacist roles in public health…” [A2-USA] 
“Well consumers have to be involved because consumers are the ultimate beneficiaries or recipients of any change … So they’re absolutely 
crucial and you can’t do this sort of research without involving consumers…” [A6-NZ] 
 Impact on funding “…any work that is being funded by the major funding bodies has to have patient public involvement (PPI) and many 
organisations will not fund research grants unless PPI has been considered.” [A3-UK] 
 
(2) Technology 
Need for technology “Without technology, we are handicapped.” [CP5-USA] 
Use of mobile technologies for 
service delivery 
“[Tele-pharmacy] could certainly transform practice and would enable pharmaceutical care to be delivered in all sorts of 
environments where currently they don’t have a pharmacist and where it wouldn’t be affordable for there to be a pharmacist.” 
[A4-UK] 
Use of databases= benefits of access 
to electronic  patient health records 
“I think that if we’re going to be asking pharmacists to be providing more clinical services, having access to that information is 
a no brainer, you have to do it otherwise you can’t make recommendations to that patient.” [A6-USA] 
Concerns about access to 
records= need for consent &  
sensitivity 
“…there might be a trust element that community pharmacies, without explicit consent of each patient” [CP3-UK] 
“However, issues regarding privacy and utilisation of these information, with / without the consent of the patient, need to be considered 
prior, and the ability to use these information will definitely affect how board pharmacy practice research can get to.” [CP8-Australia] 
 
(3) Changing 
demographics 
 
 
Effect on service delivery “…if the services that are needed are going to be quite different to what’s currently available, we want to be able to generate 
the evidence to show that the new services to be put in place are going to deliver on what is actually required.” [A3-UK] 
Effect of ethnicity and 
migration on sample data 
“...say if you look at ethnicity for example, the behavioural elements that you have to apply, say to somebody from one culture to another 
culture, is very different so you’d have to take into account that when you’re doing your research…” [A1-Australia] 
 
Language  barriers “It’s ok you know, buying your loaf and potatoes from the supermarket and not being able to communicate effectively, but it’s 
important, in fact vital for healthcare advice that is understood correctly and that the healthcare professional giving the advice 
is confident that the patient understands it.” [CP4-UK] 
Effect of an ageing population “An ageing population would be another driver for care to be delegated from doctors to other healthcare professionals, 
including pharmacists.” [A4-UK] 
“expansion of the population in general will mean that there is more need [for patients] to have the access to medical care 
including pharmaceutical care.” [A5-USA] 
“…there’s a huge investment of money with aging population. So it won’t really affect your research agenda because you are keeping 
track of that anyway.” [CP9-Australia] 
 
 
(4) Education 
and 
professional 
standards 
Lack of exposure to pharmacy  
practice research 
“I don’t think professionals generally in the past have actually been able to be exposed to that much research.” [CP3-
UK] 
“Having the students exposed to practice research while they’re still in school would help to promote further research and 
further involvement into research when they get out to practice.” [A5-USA] 
Integration  between 
researchers and pharmacists 
“… I think we need research aware individuals in the profession who are able to appreciate why research is important.” [A3-
UK] 
“I think we’ve got to develop clinical academic careers for people like doctors have. There’s a whole clinical academic 
structure for other health professionals but not for pharmacists…we’ve got to have those leaders who are half in practice and 
half not, like the medics are.” [A1-UK] 
Link between education and 
the service provided to patients 
“the number of hours spent on studying medicines actions needs to be emphasised more.” [A4-UK] 
“We expect things to change, so and that only comes from education… so continuing education is really important for changing the way.” 
[CP3-NZ] 
 “...we know when they graduate that they have these skills. How quickly those skills deteriorate …” [A5-Canada] 
 Professional standards “I think one can always evaluate the extent to which professional standards are being adhered to and one can use, utilise or 
gauge the quality of care to determine and inform the professional standards.” [A2-USA] 
“... if professional standards change we might want to evaluate them to make sure that they do the job and so in that case professional 
standards might drive the practice research.” [A3-Australia] 
  
  
4. Impact of pharmacy practice research 
 
Participants commented on important drivers for policy change and how they could be used by researchers in the future. Most participants in 
all countries emphasised the importance of having strong evidence-based research to drive meaningful policy change. They also spoke about 
how evidence of cost-effectiveness and better healthcare outcomes were important. Participants in the UK commented on research conducted 
to show the effectiveness of the New Medicine Service and how that influenced policymakers to continue funding the service.
 
They thought 
that it was important to show that the intervention worked and saved money. Participants in the USA commented on the Affordable Care Act 
and how that came into federal legislation. They mentioned that it was useful to have good advocacy which was important when influencing 
policy-makers to make changes. Participants made various suggestions for future research areas. Many of the participants from the UK 
thought that it was important to assess the quality and impact of services on patient and health services outcomes. 
Table 6: Themes that emerged from discussion surrounding impact of pharmacy practice research 
Theme Explantory note Evidence 
(1) Impact of 
pharmacy 
practice research  
Strong evidence needed  “If you want to know whether or not one service is better than another service, you would do a randomised controlled trial. If you’re 
interested in people’s attitudes or views which would go on to inform evidence and policy, then you’re probably talking about a cross-
sectional survey or qualitative work.” [A3-UK] 
“... bureaucrats, and department of health…they don’t really care unless it’s doing two things; improving health for the patients and improving access, 
and decreasing cost. So if there’s no reducing cost in emergency room visits, they don’t really care. That is the ugly truth of it.”[CP2-Canada] 
 Using the evidence in 
practice  
“given that each state has their own regulations and procedures… some states are lagging behind to embrace the results of the research….” 
[A5-USA] 
“Warfarin I’d say was one that worked, because it was funded at the right level. It was initiated by a government body… it had all sorts of barriers of 
getting ongoing funding...”[CP5-NZ] 
 Future pharmacy practice 
research areas 
 
“…we have to prove that what we do does the patient good and it saves the NHS money and make it more efficient.” [CP4-UK] 
“…chronic disease management, how pharmacists can impact the chronic diseases management is probably the biggest area that we need to focus 
on.”[CP2-Canada] 
 
 
5. Future of pharmacy practice and pharmacy practice research 
Ideas for future practice and pharmacy practice research were offerred by participants. Academics and community pharmacists provided similar 
opinions on what they thought would be important in the future across four thematic categories; (1) Key to the future of sustained pharmacy 
practice (2) How the future of pharmacy practice research will pan out (3) Issues to be researched in the future and, (4) Global impact on the 
future of pharmacy practice research. These are presented in the table below. Many ideas for future practice were elaborations of those identified 
as key issues in Section 1 of the results. 
Table 7: Themes that emerged from discussion surrounding Future of pharmacy practice and pharmacy practice research 
Theme Explantory note Evidence 
(1) Key to the 
future of 
sustained 
pharmacy 
practice 
Most participants felt that future community pharmacy 
practice would involve pharmacists providing a clinical 
service integrated with other primary care 
professionals by using electronic patient records to 
ensure services delivered are tailored to support each 
patient in the management of their care. 
 
An academic from the USA elaborated on this by saying better streamlining of care which would put the patient 
more at ease. They said it should be: “just a given that if you need an adjustment on your prescription then you 
can get that adjustment in your prescription without having to go all they way to your physician and come all 
the way back to that pharmacy again.” [A6-USA] 
“future was not sticking tablets in bottles, the need for us to do that as pharmacists is long gone we have machines 
that can do everything. Robotics at whatever level are going to influence every profession, every business, and 
industry in the world.” [CP5-NZ] 
 
 
Participants also talked about how crucial it was to 
educate pharmacists so they were adaptable to 
embracing change. 
 
“being able to keep up with the continuing education and learning what is needed in the pharmacy practice in 
the current day and in the future is vital in order to survive.” [CP2-USA] 
 
(2) How the 
future of 
pharmacy 
practice research 
will look 
Academics in particular thought that the future would 
involve a more multidisciplinary approach to pharmacy 
practice research because collaboration would secure 
better funding. They also believed that it was important 
to prepare researchers that were appropriately trained in 
pharmacy practice research. 
“In terms of pharmacy practice research, I think there needs to be the availability and commitment to good 
training and people being trained in appropriate methodologies and doing work in a rigorous and robust 
way.” [A3-UK] 
“...my hope is that the findings from pharmacy research are integrated into curriculum and advocacies and 
organisations would actually advocate on that basis.” [A5-Canada] 
 Some community pharmacists emphasised the need 
for more evaluations to show the effectiveness of 
changes occurring in pharmacy practice but many 
were concerned about the feasibility of getting 
involved in research. 
“I think we need to develop new ways of measuring and also more effective ways of measuring things so we 
can demonstrate its value.” [CP3-UK] 
 
 
(3) Issues to be 
researched in the 
future 
 
Some participants felt that they had already answered 
this question (section 4.3). Those that responded 
stated they would like to see research on the impact 
of a multidisciplinary approach to delivering 
healthcare as well as other community pharmacy 
services. 
“I’m sure lots of people will be evaluating how professions collaborate and integrate and work together. And 
whether it will be genuinely a benefit or if this leads to benefit for the patient.” [CP3-UK] 
“minor ailments services, so really just, providing OTC advice, primary care advice.” [A7-Australia] 
“I think my priority in research right now is looking at getting pharmacists to use their clinical ability” [A8-NZ] 
“…older people and their medicines, that would be my number 1.” [A2-NZ] 
One pharmacist said that it was important to prove the 
value of having a pharmacist in the primary 
healthcare team 
“I like to think there is an opportunity for us as healthcare professionals to demonstrate that in addition to the 
supply function, we can actually add lots of value and lots of important interventions into patients’ healthcare, 
conditions and lifestyles, because at the end of the day pharmacists are clinicians.” [CP4-UK] 
 
Another academic thought that integrating 
community pharmacists into research was another 
issue to develop further. 
 
“I also would like to do some more work in how researchers communicate with pharmacists and what we 
could do a better job of.” [A6-USA] 
 
(4) Global impact 
on the future of 
pharmacy 
practice research 
Although participants agreed that pharmacy practice 
meant different things in different countries, they were 
hopeful of a more internationally collaborative 
approach in the future which could bring some 
innovative models of care. Many academics indicated 
the importance of a global workforce within the field 
because they felt that there was a shortage of 
pharmacy practice researchers worldwide. Academics 
and community pharmacists from the USA talked 
about looking at international practice and research 
conducted globally that could influence their future 
scope of practice. 
“I think there’s advantages for people, especially in the US to learn from the mistakes that other people have 
made so that they don’t make those same mistakes themselves as they’re expanding the scope of practice in 
their own home country.” [A6-USA] 
 
  
6. Methods related to pharmacy practice research 
 
Participants were asked for their opinions on current and new methods or models that could be implemented in pharmacy practice research. 
Most community pharmacists struggled to answer these questions as many of them had not been involved in research.  
Table 8: Themes that emerged from discussion surrounding Methods related to pharmacy practice research 
Theme Explantory note Evidence 
Current methods 
being used 
 
Most academics agreed that methods used to conduct 
pharmacy practice research should be selected 
specifically to address the research question being 
asked. 
 
“I think it’s not so much about the current methodologies, I think it needs to be; what are the questions, how do we 
answer those questions and then at that point, if we’re not familiar with the methodologies we need to learn about 
them.” [A3- UK] 
“So there’s a room to look beyond survey and interview research methodologies in doing pharmacy practice research.” 
[CP9-Australia] 
 
 
However, many community pharmacists found it 
difficult to answer this question as they were not 
familiar with research techniques. 
 
“I’m not sure about the methodologies unfortunately.” [CP2-USA] 
“once the pharmacists start practicing community pharmacy…our brain sometimes gets shut down from the 
research thing…” [CP5-USA] 
 
New methods or 
models employed 
to conduct 
pharmacy 
practice research 
 
Many participants thought that new tools such as 
advances in technology could influence the way in 
which pharmacy practice research could be conducted. 
Participants from the USA also talked about 
technology 
“I think that technology can enable a substantial change in how research can be conducted in this era…” [A5-
USA] 
“it’ll just speed things up.” 
“...now the research is becoming much faster. You could easily get an app out there at a cheap, affordable price, and you 
know you can collate a lot more data, at a much more cost effective way.” [CP2-Canada] 
 
 
Participants also talked about a multidisciplinary 
approach to conducting research. This could also 
identify methods used in other disciplines that could 
be relevant to pharmacy practice research. 
 
“I don’t think it’s a case of just fetching a new research method or developing these, I think it’s a case of maybe 
trying to research a method which is out there, existing in the world but applying it to pharmacy practice.” [CP3-
UK] 
 
Academics also mentioned that new models are not 
often proposed by researchers but: 
 
“I think what we have to do is to make sure we are always in touch with what you might call the cutting-edge 
approaches in health service generally and make sure we adopt them as soon as we can in pharmacy practice 
research.” [A4-UK] 
 
Impact of new 
methods on 
future practice 
 
Not all participants were able to answer this question in 
detail but there was agreement that the new methods 
would better inform and impact future practice. 
“I think you should get stronger research.” [A4-UK] 
“...you will have more robust data, so you will have more reliable information coming out research. You will have more 
material to your argument.” [CP9-Australia] 
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DISCUSSION 
This study set out to explore an area that is under researched -- what a community 
pharmacy practice research agenda could look like for the future; from the viewpoint of 
academics and practitioners. Participants were able to provide their view on the current 
situation in community pharmacy within their respective countries and also discuss the 
enablers and barriers to moving the profession forward. Subsequently, this study also 
allowed the exploration of ideas on how this could be achieved by researchers. 
It has been suggested that the pharmacy profession could provide an accessible 
healthcare professional for the consumer (19), especially as budget-cuts and increases in 
the population requiring medical treatment are putting strains on healthcare delivery 
(20). According to George and colleagues (2015) a future research agenda must be based 
on the future care model, which is changing to support patients in the acute and chronic 
management of their disease (21).
 
As the pharmacy model is moving from one of a 
primarily dispensing role to one of a service-based model based on clinical activity, we 
must also consider the potential services. Services offered must include support for 
healthy living and conducting medication reviews (22).
 
 
This study highighted potential enablers and barriers to this expanded role. Community 
pharmacists felt that the general public did not understand what the pharmacist did 
outside of dispensing. This was also identified in a pilot study conducted in the UK 
where consumers had a lack of understanding of the expertise of a pharmacist and were 
therefore less supportive of t h e  expanding role of the pharmacist (23). Promotion of the 
skills held by the pharmacy profession would be one way to overcome this lack of 
understanding. This promotion should advocate for the management and delivery of 
pharmaceutical care, particularly the benefits of pharmacists being accessible to the 
community. Consumer involvement in research was also advocated for by participants in 
our research; a notion reinforced by numerous influential bodies; being strong advocates 
for consumer roles in public health research (24). 
Resources are essential in the transition to the service-based model; whether this be 
time, funding or compensation. Without adequate funding, implementation of pharmacy 
services is limited. Many community pharmacists identified time as a barrier to 
providing quality services, this is something that was also found by Jorgenson et al (18).
 
In this current study, participants felt that having competent technicians that could do the 
bulk of dispensing and the introduction of new technologies such as robot dispensing 
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could free up their time to provide clinically oriented services. This has been suggested 
previously by Smith et al (22). Our participants also thought that more collaboration 
within the primary care team such as with general practices could re-distribute workload 
and enhance patient care, particularly in the management of patients with long-term 
conditions who may be on a number of medicines. Evidence of potential benefit was 
seen in the UK with the medicines reviews being completed in pharmacies (25). In 
addition, the potential for pharmacist services in regards to triage in community 
pharmacies was described in a systematic review by Curley and colleagues (2016) (13).  
It is important to understand how pharmacy practice research could facilitate these 
changes in practice and support progression of the profession in the future. These ideas 
could therefore be the basis of a future research agenda. Academics across countries 
shared a concern that there was a lack of pharmacy practice research in general and that 
it was fundamental to have research as evidence to underpin changes in practice and 
support whether there was a benefit to the patient. Participants thought that in order to 
generate strong research, it was important to have a competent and willing workforce 
who could address the research needs of the population and adapt their work to generate 
the evidence required to inform future policy and evaluate practice. In addition, in order 
to ensure that there is the maximum uptake of the outcomes of this research, it needs to 
be multi-disciplinary. 
Evidence to support the expanding role of the pharmacist is growing; key questions still 
need to be explored,  such as, whether the pharmacist is the ultimate barrier to practice 
change (26). Our study partcipants also highlighted this; suggesting many pharmacists 
may not take up the opportunity to embrace an expanded role.
 
Studies conducted in NZ 
recognize that pharmacists themselves need to make attitudinal changes and change their 
culture (27-29) in order to implement a Vision (30) of new roles and integrate within 
primary healthcare teams (31). They need to be supported to do so (32) through new 
funding models (33). In order to bring about this change in the profession, leaders are 
required to strongly advocate for this transition of the profession. Tsuyuki et al. believes 
the role of leadership is important in facilitating the growth and evolution of the 
profession and leadership from all levels, from organizations to individual pharmacists 
will lead to change in pharmacy practice (34).(35)(35) 
Another major barrier that was highlighted was funding; academics in particular 
emphasised the need for sufficient funding for this research. Funding needs to support 
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high quality research, to conduct studies such as randomised controlled trials or service 
evaluations, especially with large data. This could be achieved by collaborations with 
researchers across disciplines, including but not limited to economists, social scientists 
and other healthcare professionals. Not only would this add value to the research with 
the collective expertise, it would also give more incentives for policymakers to allocate 
funding into the research and ensure that professional bodies are aware of the benefits 
that pharmacy practice researchers bring to improving health outcomes. An example of 
this approach can be seen in the study by Snyder and colleagues where mixed methods 
were used by a team of researchers from different health-related backgrounds to explore 
successful community pharmacist-physician collaborative working relationships 
(36).(37)
 
Most of the academics and community pharmacists interviewed thought that it would be 
beneficial to integrate research into practice, which could be achieved by encouraging 
community pharmacists to get more involved in research themselves. However, this 
comes with its own barriers; time and lack of experience were both expressed in this 
study. Previous work has also highlighted this perception; pharmacists felt that they 
didn’t know enough about research or they were concerned that they wouldn’t have time 
to conduct it in addition to other work they were required to complete (38).
 
Aiding 
communication between academics and community pharmacists via means such as 
conferences or education sessions, promoting the benefits of pharmacist participation 
could be one step to achieve this.
 
An interesting approach conducted in Australia to 
encourage engagement of community pharmacists in research was to incentivise the 
system. This was achieved by incentivising the national service model, where 
community pharmacists were given additional funding for engaging in research (39), 
albeit the outcomes havent been reported yet. 
Participants identified a wide range of issues within community pharmacy practice they 
would like to conduct research on. Academics largely focused on how research can be 
utilised in the community and how to implement findings to ensure sustainability of 
pharmacy practice research. A minority of academics would like to focus on how 
pharmacists use their clinical knowledge in the community setting, how they provide 
advice with over the counter treatments, and also how specific populations take their 
medications. 
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(40)(40)(40)(40)On the otherhand the issues that community pharmacists would like to 
research are related to the current practice model such as allocating time to provide all 
the patient focused services on top of managing a business. Some pharmacists would 
like to see a practice model which does not involve making a profit out of delivering 
pharmacy services. Whereas, other community pharmacists would like to focus on the 
issues they see every day within the community setting such as efficacy of 
extemporaneous compounds, the impact of pharmacist's advice on the health of patients 
and also issues related to chronic disease management and medication use. 
Academics agreed that the method selected depended on the research question being 
asked. It would therefore be the responsibility of the research team to choose the most 
appropriate method to conduct their study effectively. (41)Many agreed that 
advancement            of technology, particularly the use and access to large electronic 
datasets, could be a new method to utilise when conducting research, which has been 
reported elsewhere (42). With the introduction of the electronic prescription service in 
the UK for example, there could be the opportunity to utilise this data and evaluate its 
effectiveness for users (43).  
In the case of our research we wanted to explore the general question of research in the 
pharmacy practice field, the next step would be to undertake research that is more 
focused on a narrower theme, allowing more interviews to be undertaken. The themes 
identified in this study could be used as the basis of future research. This could be used 
to identify new themes or to understand whether they are representative of the views of 
the wider population of academics and community pharmacists. Following this, a 
qualitative study or mixed-methods approach could be used to test these themes within a 
larger set of primary healthcare professionals who could provide their input in evaluating 
the research needs of the population. Doing this sort of large scale study could be the 
step forward in influencing funding providers and policymakers to invest in future 
research studies for the wide-scale benefit of improved health outcomes and savings of 
money.  
As with any study this is not without its limitations and these present as potential future 
research projects. Firstly, this is a qualitative piece of work which is aiming to explore 
and understand and the findings cannot be generalised at this point. In-order to be able to 
generalise, large quantitative studies would need to be undertaken and this sits nicely 
with a future research agenda. This study is also limited to five high income countries; 
22  
albeit with different health systems. To gain a wider international understanding 
pharmacy academics and practitioners in low and middle income countries could be 
included; along with a broader range of high income European nations.    
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CONCLUSION 
This study set out to explore the views of pharmacy academics and practitioners about 
pharmacy practice and the research agenda moving forward into the future. The aim was 
to understand new methods which may be used in the future by pharmacy practice 
researchers; as perceived by practicing pharmacists and academics. Participants 
identified a wide range of issues within community pharmacy practice they would like 
to conduct research on. Academics largely focused on how research can be utilised in 
the community and how to implement findings to ensure sustainability of pharmacy 
practice research. A minority of academics would like to focus on how pharmacists use 
their clinical knowledge in the community setting, how they provide advice with over 
the counter treatments, and also how specific populations take their medications. Issues 
that community pharmacists would like to research are related to the current practice 
model such as allocating time to provide all the patient focused services on top of 
managing a business.  
Some community pharmacists would like to see research into a practice model which 
does not involve making a profit out of delivering pharmacy services while others see a 
research agenda in the issues they see every day including the efficacy of 
extemporaneous compounds, the impact of pharmacist's advice on patient outcomes and 
issues related to chronic disease management and medication use. 
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